PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

BACKGROUND: Protein Tyrosine Phosphatase Receptor-type O (PTPRO) has recently been in the spotlight as a tumor suppressor, whose encoding gene is frequently methylated in cancers. We examined the methylation status of the PTPRO gene promoter in breast cancer and evaluated the correlation between PTP...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yi-Teng, Li, Fei-Fei, Ke, Chen, Li, Zhou, Li, Zong-Tai, Zou, Xiao-Fang, Zheng, Xiao-Xuan, Chen, Yu-Ping, Zhang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852714/
https://www.ncbi.nlm.nih.gov/pubmed/24090193
http://dx.doi.org/10.1186/1479-5876-11-245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852714/
https://www.ncbi.nlm.nih.gov/pubmed/24090193
http://dx.doi.org/10.1186/1479-5876-11-245

Ejemplares similares